Brought to you by

Esprit Pharma brings in $5.14mm with its Series A round
30 Jun 2005
Executive Summary
Esprit Pharma (specialty pharmaceuticals) has brought in $5.14mm with its Series A venture round. Apax Partners, Domain Associates, and New Enterprise Associates co-led the financing.
Deal Industry
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Related Companies
Advertisement